These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 19396737)

  • 1. Databases of protein-protein interactions and their use in drug discovery.
    Fuentes G; Oyarzabal J; Rojas AM
    Curr Opin Drug Discov Devel; 2009 May; 12(3):358-66. PubMed ID: 19396737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drugging challenging targets using fragment-based approaches.
    Coyne AG; Scott DE; Abell C
    Curr Opin Chem Biol; 2010 Jun; 14(3):299-307. PubMed ID: 20223699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New in protein structure and function annotation: hotspots, single nucleotide polymorphisms and the 'Deep Web'.
    Bromberg Y; Yachdav G; Ofran Y; Schneider R; Rost B
    Curr Opin Drug Discov Devel; 2009 May; 12(3):408-19. PubMed ID: 19396742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The topology of drug-target interaction networks: implicit dependence on drug properties and target families.
    Mestres J; Gregori-Puigjané E; Valverde S; Solé RV
    Mol Biosyst; 2009 Sep; 5(9):1051-7. PubMed ID: 19668871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction networks: from protein functions to drug discovery. A review.
    Chautard E; Thierry-Mieg N; Ricard-Blum S
    Pathol Biol (Paris); 2009 Jun; 57(4):324-33. PubMed ID: 19070972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacophore-based discovery of small-molecule inhibitors of protein-protein interactions between HIV-1 integrase and cellular cofactor LEDGF/p75.
    De Luca L; Barreca ML; Ferro S; Christ F; Iraci N; Gitto R; Monforte AM; Debyser Z; Chimirri A
    ChemMedChem; 2009 Aug; 4(8):1311-6. PubMed ID: 19565598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel in vitro protein fragment complementation assay applicable to high-throughput screening in a 1536-well format.
    Hashimoto J; Watanabe T; Seki T; Karasawa S; Izumikawa M; Seki T; Iemura S; Natsume T; Nomura N; Goshima N; Miyawaki A; Takagi M; Shin-Ya K
    J Biomol Screen; 2009 Sep; 14(8):970-9. PubMed ID: 19641222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting protein-protein interactions for therapeutic intervention: a challenge for the future.
    Zinzalla G; Thurston DE
    Future Med Chem; 2009 Apr; 1(1):65-93. PubMed ID: 21426071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Docking motif-guided mapping of the interactome of protein phosphatase-1.
    Hendrickx A; Beullens M; Ceulemans H; Den Abt T; Van Eynde A; Nicolaescu E; Lesage B; Bollen M
    Chem Biol; 2009 Apr; 16(4):365-71. PubMed ID: 19389623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small-molecule stabilization of protein-protein interactions: an underestimated concept in drug discovery?
    Thiel P; Kaiser M; Ottmann C
    Angew Chem Int Ed Engl; 2012 Feb; 51(9):2012-8. PubMed ID: 22308055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A computationally guided protein-interaction screen uncovers coiled-coil interactions involved in vesicular trafficking.
    Zhang H; Chen J; Wang Y; Peng L; Dong X; Lu Y; Keating AE; Jiang T
    J Mol Biol; 2009 Sep; 392(1):228-41. PubMed ID: 19591838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evolving role of molecular diversity in drug discovery.
    Marcaurelle LA; Foley MA
    Curr Opin Chem Biol; 2010 Jun; 14(3):285-8. PubMed ID: 20472491
    [No Abstract]   [Full Text] [Related]  

  • 13. A combinatorial method to enable detailed investigation of protein-protein interactions.
    Maclagan K; Tommasi R; Laurine E; Prodromou C; Driscoll PC; Pearl LH; Reich S; Savva R
    Future Med Chem; 2011 Mar; 3(3):271-82. PubMed ID: 21446842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein interactions in 3D: from interface evolution to drug discovery.
    Winter C; Henschel A; Tuukkanen A; Schroeder M
    J Struct Biol; 2012 Sep; 179(3):347-58. PubMed ID: 22595401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Charting plant interactomes: possibilities and challenges.
    Morsy M; Gouthu S; Orchard S; Thorneycroft D; Harper JF; Mittler R; Cushman JC
    Trends Plant Sci; 2008 Apr; 13(4):183-91. PubMed ID: 18329319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smaller is better for antibiotic discovery.
    Waldrop GL
    ACS Chem Biol; 2009 Jun; 4(6):397-9. PubMed ID: 19537754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein interactions: mapping interactome networks to support drug target discovery and selection.
    De Las Rivas J; Prieto C
    Methods Mol Biol; 2012; 910():279-96. PubMed ID: 22821600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AlphaSpace: Fragment-Centric Topographical Mapping To Target Protein-Protein Interaction Interfaces.
    Rooklin D; Wang C; Katigbak J; Arora PS; Zhang Y
    J Chem Inf Model; 2015 Aug; 55(8):1585-99. PubMed ID: 26225450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mining and visualizing the chemical content of large databases.
    Villar HO; Hansen MR
    Curr Opin Drug Discov Devel; 2009 May; 12(3):367-75. PubMed ID: 19396738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the purinome.
    Murray JM; Bussiere DE
    Methods Mol Biol; 2009; 575():47-92. PubMed ID: 19727611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.